{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "OpEd", "lead_paragraph": "The truth is, we\u2019ve always had reason to question the idea that cholesterol is an agent of disease.", "headline": {"main": "What\u2019s Cholesterol Got to Do With It?", "kicker": "Op-Ed Contributor", "print_headline": "What\u2019s Cholesterol Got to Do With It?", "content_kicker": "Op-Ed Contributor"}, "abstract": null, "print_page": "18", "word_count": "1224", "_id": "547d3d2c798810275e384344", "snippet": "The truth is, we\u2019ve always had reason to question the idea that cholesterol is an agent of disease.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/27/opinion/27taubes.html", "multimedia": [{"subtype": "wide", "url": "images/2008/01/27/opinion/27opart.190h.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2008/01/27/opinion/27opart.190h.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2008/01/27/opinion/27opart.600.jpg", "height": 280, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2008/01/27/opinion/27opart.600.jpg", "xlargeheight": "280"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2008/01/27/opinion/27opart.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/01/27/opinion/27opart.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Cholesterol", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Zetia (Drug)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Tests and Testing", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "National Institutes of Health", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "8", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gary", "lastname": "TAUBES"}], "original": "By GARY TAUBES"}, "document_type": "article", "pub_date": "2008-01-27T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Question", "blog": [], "news_desk": "National", "lead_paragraph": "The transcript of Kevin Sack\u2019s interview with John Edwards.", "headline": {"main": "Edwards on Health Care", "content_kicker": "Transcript"}, "abstract": null, "print_page": null, "word_count": "5644", "_id": "547d3616798810275e384299", "snippet": "The transcript of Kevin Sack\u2019s interview with John Edwards.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/25/us/politics/25edwards-text.html", "multimedia": [], "subsection_name": "Politics", "keywords": [{"rank": "1", "is_major": "N", "value": "Edwards, John", "name": "persons"}, {"rank": "2", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Presidential Election of 2008", "name": "subject"}], "byline": null, "document_type": "article", "pub_date": "2008-01-25T12:17:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Notable studies now enrolling patients.", "headline": {"main": "Selected Studies: Bipolar Disorder", "kicker": "Clinical Trials", "print_headline": "Selected Studies: Bipolar Disorder", "content_kicker": "Clinical Trials"}, "abstract": null, "print_page": null, "word_count": "309", "_id": "5342d0b47988106f3076e466", "snippet": "Notable studies now enrolling patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/ref/health/healthguide/esn-bipolar-trials.html", "multimedia": [], "subsection_name": "Health Guide", "keywords": [{"value": "Bipolar Disorder", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "2", "name": "subject"}], "byline": null, "document_type": "article", "pub_date": "2008-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Drug makers are being asked for the first time to put a comprehensive suicide assessment into clinical trials.", "headline": {"main": "F.D.A. Requiring Suicide Studies in Drug Trials", "sub": "Concern on Psychiatric Risk in Broad Range of Treatments  ;", "print_headline": "F.D.A. Requiring Suicide Studies In Drug Trials"}, "abstract": null, "print_page": "1", "word_count": "1188", "_id": "547bfeaf798810629fb0cac8", "snippet": "Drug makers are being asked for the first time to put a comprehensive suicide assessment into clinical trials.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/24/washington/24fda.html", "multimedia": [{"subtype": "wide", "url": "images/2008/01/23/washington/20080124_FDA_GRAPHIC.190jpg.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2008/01/23/washington/20080124_FDA_GRAPHIC.190jpg.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2008/01/23/washington/20080124_FDA_GRAPHIC.190jpg.jpg", "height": 126, "width": 190, "legacy": {"thumbnailheight": "126", "thumbnail": "images/2008/01/23/washington/20080124_FDA_GRAPHIC.190jpg.jpg", "thumbnailwidth": "190"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Food and Drug Administration", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Depression (Mental)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Suicides and Suicide Attempts", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Tests and Testing", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2008-01-24T00:00:00Z", "section_name": "Washington"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Talking points for patients and physicians.", "headline": {"main": "What to Ask About Hypertension", "kicker": "Questions for Your Doctor", "print_headline": "What to Ask About Hypertension", "content_kicker": "Questions for Your Doctor"}, "abstract": null, "print_page": null, "word_count": "966", "_id": "5342be0b7988107fc3649f4c", "snippet": "Talking points for patients and physicians.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/ref/health/healthguide/esn-hypertension-ask.html", "multimedia": [], "subsection_name": "Health Guide", "keywords": [{"value": "Research", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Hypertension", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Salt", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Weight", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Blood Pressure", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Eric", "lastname": "SABO"}], "original": "By ERIC SABO"}, "document_type": "article", "pub_date": "2008-01-24T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Notable research studies now enrolling patients.", "headline": {"main": "Selected Studies: Hypertension", "kicker": "Clinical Trials", "print_headline": "Selected Studies: Hypertension", "content_kicker": "Clinical Trials"}, "abstract": null, "print_page": null, "word_count": "378", "_id": "5342be097988107fc3649f4a", "snippet": "Notable research studies now enrolling patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/ref/health/healthguide/esn-hypertension-trials.html", "multimedia": [], "subsection_name": "Health Guide", "keywords": [{"value": "Hypertension", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Blood Pressure", "is_major": "N", "rank": "2", "name": "subject"}], "byline": null, "document_type": "article", "pub_date": "2008-01-24T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Question", "blog": [], "news_desk": "Science", "lead_paragraph": "Dr. Aram Chobanian on the stepwise risks of high blood pressure", "headline": {"main": "The Worldwide Challenge of Blood Pressure Control", "kicker": "Expert Q & A", "print_headline": "The Worldwide Challenge of Blood Pressure Control", "content_kicker": "Expert Q & A"}, "abstract": null, "print_page": null, "word_count": "1524", "_id": "5342be097988107fc3649f49", "snippet": "Dr. Aram Chobanian on the stepwise risks of high blood pressure", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/ref/health/healthguide/esn-hypertension-expertvoice.html", "multimedia": [], "subsection_name": "Health Guide", "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Hypertension", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Diet and Nutrition", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Salt", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Blood Pressure", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "4", "name": "subject"}], "byline": null, "document_type": "article", "pub_date": "2008-01-24T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Metro", "lead_paragraph": "Gov. Eliot Spitzer of New York proposed an array of taxes and fees and almost $1 billion in health care cuts, and scaled back plans for new education aid and property tax relief.", "headline": {"main": "Spitzer Plans Cuts and Fees to Close Deficit of $4.4 Billion", "print_headline": "Spitzer Plans Cuts and Fees To Close Deficit Of $4.4 Billion"}, "abstract": null, "print_page": "1", "word_count": "1239", "_id": "547d1f7b798810275e38409e", "snippet": "Gov. Eliot Spitzer of New York proposed an array of taxes and fees and almost $1 billion in health care cuts, and scaled back plans for new education aid and property tax relief.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/23/nyregion/23albany.html", "multimedia": [{"subtype": "xlarge", "url": "images/2008/01/22/nyregion/23albany_600.jpg", "height": 280, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2008/01/22/nyregion/23albany_600.jpg", "xlargeheight": "280"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2008/01/22/nyregion/23albany_75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/01/22/nyregion/23albany_75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Spitzer, Eliot L", "is_major": "N", "rank": "1", "name": "persons"}, {"value": "Budgets and Budgeting", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Finances", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Politics and Government", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Albany (NY)", "is_major": "N", "rank": "5", "name": "glocations"}], "byline": {"contributor": "Trymaine Lee contributed reporting.", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Danny", "lastname": "HAKIM"}], "original": "By DANNY HAKIM"}, "document_type": "article", "pub_date": "2008-01-23T00:00:00Z", "section_name": "N.Y. / Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "The cholesterol drug Vytorin is now getting attention that is anything but funny.", "headline": {"seo": "Zetia - Cholesterol - Drug Trials - Heart - Medicine and Health", "main": "What That Cholesterol Trial Didn\u2019t Show", "kicker": "Well", "print_headline": "What That Cholesterol Trial Showed, and What It Didn\u2019t", "content_kicker": "Well"}, "abstract": null, "print_page": "1", "word_count": "918", "_id": "547d1269798810275e383f75", "snippet": "The cholesterol drug Vytorin is now getting attention that is anything but funny.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/22/health/22well.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2008/01/21/health/22well75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/01/21/health/22well75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Zetia (Drug)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Cholesterol", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tara", "lastname": "PARKER-POPE"}], "original": "By TARA PARKER-POPE"}, "document_type": "article", "pub_date": "2008-01-22T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 9, "offset": 0, "time": 73}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}